{"CVE Code": "CVE-2023-33365", "Description": "A path traversal vulnerability exists in Suprema BioStar 2 before 2.9.1, which allows unauthenticated attackers to fetch arbitrary files from the server's web server.", "NVD Link": "https://nvd.nist.gov/vuln/detail/CVE-2023-33365", "Vulnerability Categories": "Directory traversal", "Affected Products": "\nSupremainc\u00bbBiostar 2Versions  before (<) 2.9.1cpe:2.3:a:supremainc:biostar_2:*:*:*:*:*:*:*:*Matching versions", "EPSS Score": "0.16% Probability of exploitation activity in the next 30 days\n~ 53 % Percentile, the proportion of vulnerabilities that are scored at or less", "EPSS History": "\n #  Date  Old EPSS Score  New EPSS Score  Delta (New - Old) \n 1  2024-09-04  0.15%  0.16%  +0.01 \n 2  2024-08-09  0.12%  0.15%  +0.03 \n 3  2024-07-03  0.10%  0.12%  +0.02 \n 4  2023-08-10  0.04%  0.10%  +0.05 ", "CVSS Scores": "7.5", "CWE": [{"CWE_ID": "CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')", "CWE_link": "/cwe-details/22/Improper-Limitation-of-a-Pathname-to-a-Restricted-Directory-.html"}], "Reference": [{"ref_link": "https://claroty.com/team82/disclosure-dashboard/cve-2023-33365", "ref_desc": "CVE-2023-33365 | ClarotyThird Party Advisory", "ref_cve_link": "N/A"}, {"ref_link": "https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291", "ref_desc": "Version 2.9.1 (V2.9.1.25) []Release Notes;Vendor AdvisoryCVEs referencing this url", "ref_cve_link": "https://www.cvedetails.com/reference-url-info/V7zv61JkQEPzvOfv9RWJI_-DimA.html"}]}